PDDHX Performance — PGIM Target Date 2020 Fund, Class R5
Data updated: 2026-10-13
PDDHX returned +5.46% year to date and +10.77% over one year to Jul 2026. Annualised returns are +9.00% over 3 years and +4.55% over 5 years. The fund trailed its Target-Date category average: $100 invested three years ago grew to $130, against $146 for the category, and to $111 over one year, against $116. Volatility over the past three years was 6.41% a year. In the 12 months to Jul 2026 the fund lost a net $6.5M, and assets reached $29.13M.
PDDHX Growth of $100
What $100 invested in PGIM Target Date 2020 Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Target-Date category average over the same months.
| Period | PDDHX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $111 | $116 |
| 3 years (Aug 2023 – Jul 2026) | $130 | $146 |
| 5 years (Aug 2021 – Jul 2026) | $125 | $142 |
| Since data start (Aug 2019 – Jul 2026) | $154 | $186 |
PDDHX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +5.46% |
| 1 year | +10.77% |
| 3 years (annualised) | +9.00% |
| 5 years (annualised) | +4.55% |
PDDHX Annual Returns
Calendar-year total returns of PGIM Target Date 2020 Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +5.46% |
| 2025 | +11.13% |
| 2024 | +7.39% |
| 2023 | +10.12% |
| 2022 | −12.11% |
| 2021 | +11.38% |
| 2020 | +8.81% |
| 2019 (Aug–Dec) | +4.63% |
PDDHX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.7% | +1.8% | −2.6% | +3.8% | +1.1% | −0.4% | 0.0% | — | — | — | — | — |
| 2025 | +1.7% | +1.2% | −1.1% | 0.0% | +1.5% | +2.3% | +0.1% | +1.9% | +1.5% | +0.9% | +0.7% | −0.1% |
| 2024 | +0.1% | +0.8% | +1.9% | −2.5% | +2.7% | +0.9% | +1.8% | +1.7% | +1.7% | −1.9% | +2.1% | −2.0% |
| 2023 | +4.1% | −2.4% | +1.9% | +0.7% | −1.3% | +2.3% | +1.6% | −1.2% | −2.7% | −1.7% | +5.0% | +3.7% |
| 2022 | −2.4% | −0.7% | +0.4% | −4.2% | −0.1% | −5.2% | +5.1% | −2.9% | −6.9% | +2.8% | +4.3% | −2.4% |
| 2021 | −0.1% | +0.8% | +1.2% | +2.8% | +1.1% | +1.0% | +1.7% | +0.8% | −2.0% | +2.6% | −0.9% | +2.1% |
| 2020 | +0.4% | −3.1% | −8.4% | +5.6% | +2.7% | +1.8% | +3.0% | +2.4% | −1.6% | −1.2% | +5.4% | +2.4% |
| 2019 | — | — | — | — | — | — | — | +0.4% | +0.5% | +1.2% | +1.1% | +1.4% |
PDDHX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 6.41%
- 3-year Sharpe ratio: 0.70 (vs 4.5% risk-free rate)
- Best month: +4.99% (Nov 2023)
- Worst month: −2.73% (Sep 2023)
PDDHX Fund Flows
Monthly money in and out of PGIM Target Date 2020 Fund, from SEC Form N-PORT.
- 12-month net flow: −$6.5M
- 12-month gross sales (incl. reinvestments): $4.0M
- Sales ÷ redemptions: 0.38×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $684K | $140K | $543K |
| Jun 2026 | $212K | $390K | −$178K |
| May 2026 | $45K | $2.8M | −$2.8M |
| Apr 2026 | $20K | $399K | −$379K |
| Mar 2026 | $77K | $2.4M | −$2.3M |
| Feb 2026 | $32K | $416K | −$384K |
| Jan 2026 | $26K | $1.4M | −$1.3M |
| Dec 2025 | $1.7M | $198K | $1.5M |
| Nov 2025 | $807K | $920K | −$112K |
| Oct 2025 | $265K | $213K | $53K |
| Sep 2025 | $36K | $969K | −$933K |
| Aug 2025 | $31K | $208K | −$177K |
PDDHX Assets Under Management
Net assets of PGIM Target Date 2020 Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $29.13M |
| 2026-04-30 | $31.36M |
| 2026-01-30 | $33.51M |
| 2025-10-31 | $34.20M |
| 2025-07-31 | $33.77M |
| 2025-04-30 | $32.45M |
| 2025-01-31 | $34.07M |
| 2024-10-31 | $34.96M |
| 2024-07-31 | $35.48M |
| 2024-04-30 | $33.88M |
| 2024-01-31 | $35.17M |
| 2023-10-31 | $38.37M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.